2 Biotechs Brave Volatility To Raise $401M In Follow-Ons
Two publicly traded life science companies braved recent market volatility and priced follow-on offerings that netted $401 million total late on Wednesday, led by Danish firm Ascendis Pharma A/S, which raised...To view the full article, register now.
Already a subscriber? Click here to view full article